Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The G protein beta-gamma (Gβγ) subunit complex is a stable dimer that acts as a key signaling transducer in the heterotrimeric G protein system. Following the activation of G protein-coupled receptors (GPCRs) by extracellular ligands, the Gα subunit exchanges GDP for GTP and dissociates from the Gβγ dimer, enabling Gβγ to interact with and regulate various effector proteins (Smrcka, 2008). These effectors include G protein-coupled inward-rectifier potassium (GIRK) channels, N-type calcium channels, and enzymes like phospholipase C beta (PLCβ) and phosphoinositide 3-kinase (PI3K). Gβγ signaling is essential for normal physiological functions such as heart rate regulation and immune cell chemotaxis, but its dysregulation is implicated in diseases like heart failure, where it contributes to pathological remodeling, and cancer, where it promotes metastasis (Kamal et al., 2011). Therapeutic targeting of Gβγ involves small molecules like gallein that bind to the dimer's surface and block its ability to engage with specific effectors, providing a novel approach to treating GPCR-related pathologies without directly targeting the receptors themselves (Bonacci et al., 2006).
Inhibition of Gβγ-effector interactions by binding to the effector-interaction surface of the Gβγ dimer, thereby preventing the activation of downstream signaling pathways such as PI3Kγ and PLCβ2 (Smrcka, 2008; Bonacci et al., 2006).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein beta-gamma subunit complex (Gβγ) (Gβγ).